In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Progenics Pharmaceuticals, Inc.

http://www.progenics.com

Latest From Progenics Pharmaceuticals, Inc.

Smith & Nephew To Acquire CartiHeal For Up To $330M

Smith & Nephew said it will acquire sports medicine technology company CartiHeal for up to $330m to boost its knee injury repair portfolio.

M & A Orthopedics

Reviva’s First Phase III Schizophrenia Readout Rivals Karuna’s Stellar KarXT

Small cap biopharma firm Reviva Pharmaceuticals reported intriguing Phase III results for its schizophrenia candidate brilaroxazine that are at least on par with Karuna’s closely watched drug.

Clinical Trials Strategy

The Runners And Riders In Hidradenitis Suppurativa

Despite its Phase III blow-up, Acelyrin is continuing to back izokibep in the skin disease. But other developers are trying immune agents old and new in what could turn into a billion-dollar market. 

Research & Development Clinical Trials

Schizophrenia, Depression And Neuropathy: What’s Coming In 2024

The following four neurological products are likely to reach market next year. Carving out sales will be an entirely different problem. 

Approvals Neurology
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • Molecular Imaging
  • Digital Health
    • Artificial Intelligence
  • Biotechnology
    • Large Molecule
      • Antibodies
    • Drug Discovery Tools
      • ADMET
  • Other Names / Subsidiaries
    • Molecular Insight Pharmaceuticals, Inc.
    • PSMA Development Company
    • UR Labs (URL)
UsernamePublicRestriction

Register